Arnett-Mansfield Rebecca L, Graham J Dinny, Hanson Adrienne R, Mote Patricia A, Gompel Anne, Scurr Lyndee L, Gava Natalie, de Fazio Anna, Clarke Christine L
Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales 2145, Australia.
Mol Endocrinol. 2007 Jan;21(1):14-29. doi: 10.1210/me.2006-0041. Epub 2006 Oct 4.
The progesterone receptor (PR) is a critical mediator of progesterone action in the female reproductive system. Expressed in the human as two proteins, PRA and PRB, the receptor is a ligand-activated nuclear transcription factor that regulates transcription by interaction with protein cofactors and binding to specific response elements in target genes. We previously reported that PR was located in discrete subnuclear foci in human endometrium. In this study, we investigated the role of ligand in the formation of PR foci and their association with transcriptional activity. PR foci were detected in mouse uterus and normal human breast tissues and were more abundant when circulating progesterone was high. In human malignant tissues, PR foci were aberrant: foci were larger in endometrial cancers than in normal endometrium, and in breast cancers hormone-dependence was decreased. Chromatin disruption also increased foci size and decreased ligand dependence, suggesting that altered nuclear architecture may contribute to the aberrant PR foci observed in endometrial and breast cancers. In breast cancer cells, movement of PR into foci required exposure to ligand and was blocked by transcriptional inhibitors and by prolonged inhibition of proteasomal degradation. Foci contained PR dimers, and fluorescence resonance energy transfer demonstrated that PR foci contained the highest concentration of receptor dimers in the nucleus. PR in foci colocalized with transcription factors and nascent RNA transcripts only in the presence of ligand, and inhibition of coactivator recruitment inhibited PR foci formation. The demonstration that focal distribution of PR within the nucleus is associated with transcription suggests a link between the subnuclear distribution of PR and its transcriptional activity that is likely to be important for normal cellular function of PR.
孕激素受体(PR)是女性生殖系统中孕激素作用的关键介质。该受体在人类中以两种蛋白PRA和PRB的形式表达,是一种配体激活的核转录因子,通过与蛋白质辅因子相互作用并结合靶基因中的特定反应元件来调节转录。我们之前报道过PR定位于人类子宫内膜的离散核内亚结构域。在本研究中,我们调查了配体在PR亚结构域形成中的作用及其与转录活性的关联。在小鼠子宫和正常人类乳腺组织中检测到PR亚结构域,并且在循环孕激素水平高时更为丰富。在人类恶性组织中,PR亚结构域异常:子宫内膜癌中的亚结构域比正常子宫内膜中的更大,并且在乳腺癌中激素依赖性降低。染色质破坏也增加了亚结构域大小并降低了配体依赖性,这表明核结构改变可能导致在子宫内膜癌和乳腺癌中观察到的异常PR亚结构域。在乳腺癌细胞中,PR进入亚结构域的移动需要暴露于配体,并被转录抑制剂和蛋白酶体降解的长期抑制所阻断。亚结构域包含PR二聚体,荧光共振能量转移表明PR亚结构域在细胞核中包含最高浓度的受体二聚体。仅在配体存在的情况下,亚结构域中的PR与转录因子和新生RNA转录本共定位,并且共激活因子募集的抑制抑制了PR亚结构域的形成。PR在细胞核内的局灶性分布与转录相关的证明表明PR的核内分布与其转录活性之间存在联系,这可能对PR的正常细胞功能很重要。